Sign in

CIK 0001933567

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Neuraxis, INC

Sign in to watch
Ticker
NRXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455079684
Phone
+1 812-689-0791
Business address
11611 N. MERIDIAN ST, SUITE 330, CARMEL, IN, 46032
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Other events
  5. 4 Open-market buy Chief Executive Officer bought 268 shares at $4.84 ($1,297)
  6. 4 Open-market buy CRO, CCO, CPO bought 328 shares at $4.84 ($1,588)
  7. 4 Open-market buy Chief Financial Officer bought 1,937 shares at $4.84 ($9,375)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award CRO, CCO, CPO acquired 193,678 shares (grant or award)
  10. 4 Grant or award CMO, SVP Science & Tech acquired 199,106 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 199,188 shares (grant or award)
  12. 8-K Event Executive or director change · Other events
  13. 4 Grant or award Director acquired 26,073 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 26,073 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 31,134 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Director acquired 86,224 shares (grant or award)

Page 1 of 10 · 196 filings